Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2014

Open Access 01-01-2014 | Original Article

Cross-sectional observational study of 208 patients with non-classical urea cycle disorders

Authors: Corinne M. Rüegger, Martin Lindner, Diana Ballhausen, Matthias R. Baumgartner, Skadi Beblo, Anibh Das, Matthias Gautschi, Esther M. Glahn, Sarah C. Grünert, Julia Hennermann, Michel Hochuli, Martina Huemer, Daniela Karall, Stefan Kölker, Robin H. Lachmann, Amelie Lotz-Havla, Dorothea Möslinger, Jean-Marc Nuoffer, Barbara Plecko, Frank Rutsch, René Santer, Ute Spiekerkoetter, Christian Staufner, Tamar Stricker, Frits A. Wijburg, Monique Williams, Peter Burgard, Johannes Häberle

Published in: Journal of Inherited Metabolic Disease | Issue 1/2014

Login to get access

Abstract

Urea cycle disorders (UCDs) are inherited disorders of ammonia detoxification often regarded as mainly of relevance to pediatricians. Based on an increasing number of case studies it has become obvious that a significant number of UCD patients are affected by their disease in a non-classical way: presenting outside the newborn period, following a mild course, presenting with unusual clinical features, or asymptomatic patients with only biochemical signs of a UCD. These patients are surviving into adolescence and adulthood, rendering this group of diseases clinically relevant to adult physicians as well as pediatricians. In preparation for an international workshop we collected data on all patients with non-classical UCDs treated by the participants in 20 European metabolic centres. Information was collected on a cohort of 208 patients 50% of which were ≥ 16 years old. The largest subgroup (121 patients) had X-linked ornithine transcarbamylase deficiency (OTCD) of whom 83 were female and 29% of these were asymptomatic. In index patients, there was a mean delay from first symptoms to diagnosis of 1.6 years. Cognitive impairment was present in 36% of all patients including female OTCD patients (in 31%) and those 41 patients identified presymptomatically following positive newborn screening (in 12%). In conclusion, UCD patients with non-classical clinical presentations require the interest and care of adult physicians and have a high risk of neurological complications. To improve the outcome of UCDs, a greater awareness by health professionals of the importance of hyperammonemia and UCDs, and ultimately avoidance of the still long delay to correctly diagnose the patients, is crucial.
Literature
go back to reference Berning C, Bieger I, Pauli S et al (2008) Investigation of citrullinemia type I variants by in vitro expression studies. Hum Mutat 29:1222–1227PubMedCrossRef Berning C, Bieger I, Pauli S et al (2008) Investigation of citrullinemia type I variants by in vitro expression studies. Hum Mutat 29:1222–1227PubMedCrossRef
go back to reference Bogdanovic MD, Kidd D, Briddon A, Duncan JS, Land JM (2000) Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry 69:813–815PubMedCrossRef Bogdanovic MD, Kidd D, Briddon A, Duncan JS, Land JM (2000) Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry 69:813–815PubMedCrossRef
go back to reference Brusilow S, Horwich A (2001) Urea cycle enzymes. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1909–1963 Brusilow S, Horwich A (2001) Urea cycle enzymes. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1909–1963
go back to reference Brusilow SW, Maestri NE (1996) Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 43:127–170PubMed Brusilow SW, Maestri NE (1996) Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 43:127–170PubMed
go back to reference Davis PK, Wu G (1998) Compartmentation and kinetics of urea cycle enzymes in porcine enterocytes. Comp Biochem Physiol B Biochem Mol Biol 119:527–537PubMedCrossRef Davis PK, Wu G (1998) Compartmentation and kinetics of urea cycle enzymes in porcine enterocytes. Comp Biochem Physiol B Biochem Mol Biol 119:527–537PubMedCrossRef
go back to reference Dionisi-Vici C, Rizzo C, Burlina AB, Caruso U, Sabetta G, Uziel G, Abeni D (2002) Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 140:321–327PubMedCrossRef Dionisi-Vici C, Rizzo C, Burlina AB, Caruso U, Sabetta G, Uziel G, Abeni D (2002) Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 140:321–327PubMedCrossRef
go back to reference Enns GM (2008) Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol 15:132–139PubMedCrossRef Enns GM (2008) Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol 15:132–139PubMedCrossRef
go back to reference Felig DM, Brusilow SW, Boyer JL (1995) Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency. Gastroenterology 109:282–284PubMedCrossRef Felig DM, Brusilow SW, Boyer JL (1995) Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency. Gastroenterology 109:282–284PubMedCrossRef
go back to reference Ficicioglu C, Mandell R, Shih VE (2009) Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening. Mol Genet Metab 98:273–277PubMedCentralPubMedCrossRef Ficicioglu C, Mandell R, Shih VE (2009) Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening. Mol Genet Metab 98:273–277PubMedCentralPubMedCrossRef
go back to reference Genet S, Cranston T, Middleton-Price HR (2000) Mutation detection in 65 families with a possible diagnosis of ornithine carbamoyltransferase deficiency including 14 novel mutations. J Inherit Metab Dis 23:669–676PubMedCrossRef Genet S, Cranston T, Middleton-Price HR (2000) Mutation detection in 65 families with a possible diagnosis of ornithine carbamoyltransferase deficiency including 14 novel mutations. J Inherit Metab Dis 23:669–676PubMedCrossRef
go back to reference Häberle J, Pauli S, Schmidt E, Schulze-Eilfing B, Berning C, Koch HG (2003) Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). Mol Genet Metab 80:302–306PubMedCrossRef Häberle J, Pauli S, Schmidt E, Schulze-Eilfing B, Berning C, Koch HG (2003) Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). Mol Genet Metab 80:302–306PubMedCrossRef
go back to reference Häberle J, Shchelochkov OA, Wang J et al (2011) Molecular defects in human carbamoyl phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Hum Mutat 32:579–589PubMedCrossRef Häberle J, Shchelochkov OA, Wang J et al (2011) Molecular defects in human carbamoyl phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Hum Mutat 32:579–589PubMedCrossRef
go back to reference Häussinger D (1990) Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J 267:281–290PubMed Häussinger D (1990) Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J 267:281–290PubMed
go back to reference Honeycutt D, Callahan K, Rutledge L, Evans B (1992) Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Neurology 42:666–668PubMedCrossRef Honeycutt D, Callahan K, Rutledge L, Evans B (1992) Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Neurology 42:666–668PubMedCrossRef
go back to reference Kleijer WJ, Garritsen VH, Linnebank M et al (2002) Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families. J Inherit Metab Dis 25:399–410PubMedCrossRef Kleijer WJ, Garritsen VH, Linnebank M et al (2002) Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families. J Inherit Metab Dis 25:399–410PubMedCrossRef
go back to reference Kölker S, Dobbelaere D, Chakrapani A et al (2011) European registry and network for intoxication type metabolic diseases (E-IMD) (Abstract). J Inher Metab Dis 34:S93CrossRef Kölker S, Dobbelaere D, Chakrapani A et al (2011) European registry and network for intoxication type metabolic diseases (E-IMD) (Abstract). J Inher Metab Dis 34:S93CrossRef
go back to reference Lee PJ (2006) Hyperammonaemia in adolescence and adulthood. In: Bachmann C, Häberle J, Leonard J (eds) Pathophysiology and management of hyperammonaemia. SPS Verlagsgesellschaft, Heilbronn, pp 93–99 Lee PJ (2006) Hyperammonaemia in adolescence and adulthood. In: Bachmann C, Häberle J, Leonard J (eds) Pathophysiology and management of hyperammonaemia. SPS Verlagsgesellschaft, Heilbronn, pp 93–99
go back to reference Lee B, Singh RH, Rhead WJ, Sniderman King L, Smith W, Summar ML (2005) Considerations in the difficult-to-manage urea cycle disorder patient. Crit Care Clin 21:S19–S25PubMedCrossRef Lee B, Singh RH, Rhead WJ, Sniderman King L, Smith W, Summar ML (2005) Considerations in the difficult-to-manage urea cycle disorder patient. Crit Care Clin 21:S19–S25PubMedCrossRef
go back to reference Legras A, Labarthe F, Maillot F, Garrigue MA, Kouatchet A, Ogier de Baulny H (2002) Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations. Crit Care Med 30:241–244PubMedCrossRef Legras A, Labarthe F, Maillot F, Garrigue MA, Kouatchet A, Ogier de Baulny H (2002) Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations. Crit Care Med 30:241–244PubMedCrossRef
go back to reference Maestri NE, Lord C, Glynn M, Bale A, Brusilow SW (1998) The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Medicine (Baltimore) 77:389–397CrossRef Maestri NE, Lord C, Glynn M, Bale A, Brusilow SW (1998) The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Medicine (Baltimore) 77:389–397CrossRef
go back to reference Mercimek-Mahmutoglu S, Moeslinger D, Häberle J et al (2010) Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab 100:24–28PubMedCrossRef Mercimek-Mahmutoglu S, Moeslinger D, Häberle J et al (2010) Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab 100:24–28PubMedCrossRef
go back to reference Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500–1505PubMedCrossRef Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500–1505PubMedCrossRef
go back to reference Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28:407–414PubMedCrossRef Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28:407–414PubMedCrossRef
go back to reference Picca S, Dionisi-Vici C, Abeni D et al (2001) Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16:862–867PubMedCrossRef Picca S, Dionisi-Vici C, Abeni D et al (2001) Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16:862–867PubMedCrossRef
go back to reference Rowe PC, Newman SL, Brusilow SW (1986) Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 314:541–547PubMedCrossRef Rowe PC, Newman SL, Brusilow SW (1986) Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 314:541–547PubMedCrossRef
go back to reference Salek J, Byrne J, Box T, Longo N, Sussman N (2010) Recurrent liver failure in a 25-year-old female. Liver Transpl 16:1049–1053PubMedCrossRef Salek J, Byrne J, Box T, Longo N, Sussman N (2010) Recurrent liver failure in a 25-year-old female. Liver Transpl 16:1049–1053PubMedCrossRef
go back to reference Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis 29:261–274PubMedCrossRef Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis 29:261–274PubMedCrossRef
go back to reference Schimanski U, Krieger D, Horn M, Stremmel W, Wermuth B, Theilmann L (1996) A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy. Hepatology 24:1413–1415PubMedCrossRef Schimanski U, Krieger D, Horn M, Stremmel W, Wermuth B, Theilmann L (1996) A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy. Hepatology 24:1413–1415PubMedCrossRef
go back to reference Smith W, Kishnani PS, Lee B et al (2005) Urea cycle disorders: clinical presentation outside the newborn period. Crit Care Clin 21:S9–S17PubMedCrossRef Smith W, Kishnani PS, Lee B et al (2005) Urea cycle disorders: clinical presentation outside the newborn period. Crit Care Clin 21:S9–S17PubMedCrossRef
go back to reference Snebold NG, Rizzo JF, Lessell S, Pruett RC (1987) Transient visual loss in ornithine transcarbamoylase deficiency. Am J Ophthalmol 104:407–412PubMed Snebold NG, Rizzo JF, Lessell S, Pruett RC (1987) Transient visual loss in ornithine transcarbamoylase deficiency. Am J Ophthalmol 104:407–412PubMed
go back to reference Summar ML, Dobbelaere D, Brusilow S, Lee B (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 97:1420–1425PubMedCentralPubMedCrossRef Summar ML, Dobbelaere D, Brusilow S, Lee B (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 97:1420–1425PubMedCentralPubMedCrossRef
go back to reference Thurlow VR, Asafu-Adjaye M, Agalou S, Rahman Y (2010) Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency. Ann Clin Biochem 47:279–281PubMedCrossRef Thurlow VR, Asafu-Adjaye M, Agalou S, Rahman Y (2010) Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency. Ann Clin Biochem 47:279–281PubMedCrossRef
go back to reference Tuchman M (1992) The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency. J Lab Clin Med 120:836–850PubMed Tuchman M (1992) The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency. J Lab Clin Med 120:836–850PubMed
go back to reference Tuchman M, Matsuda I, Munnich A, Malcolm S, Strautnieks S, Briede T (1995) Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency. Am J Med Genet 55:67–70PubMedCrossRef Tuchman M, Matsuda I, Munnich A, Malcolm S, Strautnieks S, Briede T (1995) Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency. Am J Med Genet 55:67–70PubMedCrossRef
go back to reference Tuchman M, Lee B, Lichter-Konecki U et al (2008) Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab 94:397–402PubMedCentralPubMedCrossRef Tuchman M, Lee B, Lichter-Konecki U et al (2008) Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab 94:397–402PubMedCentralPubMedCrossRef
go back to reference Wilcken B (2004) Problems in the management of urea cycle disorders. Mol Genet Metab 81(Suppl 1):S86–S91PubMedCrossRef Wilcken B (2004) Problems in the management of urea cycle disorders. Mol Genet Metab 81(Suppl 1):S86–S91PubMedCrossRef
go back to reference Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M (2006) Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat 27:626–632PubMedCrossRef Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M (2006) Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat 27:626–632PubMedCrossRef
Metadata
Title
Cross-sectional observational study of 208 patients with non-classical urea cycle disorders
Authors
Corinne M. Rüegger
Martin Lindner
Diana Ballhausen
Matthias R. Baumgartner
Skadi Beblo
Anibh Das
Matthias Gautschi
Esther M. Glahn
Sarah C. Grünert
Julia Hennermann
Michel Hochuli
Martina Huemer
Daniela Karall
Stefan Kölker
Robin H. Lachmann
Amelie Lotz-Havla
Dorothea Möslinger
Jean-Marc Nuoffer
Barbara Plecko
Frank Rutsch
René Santer
Ute Spiekerkoetter
Christian Staufner
Tamar Stricker
Frits A. Wijburg
Monique Williams
Peter Burgard
Johannes Häberle
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9624-0

Other articles of this Issue 1/2014

Journal of Inherited Metabolic Disease 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.